Search results for "Uterine Cervical Neoplasms..."

showing 10 items of 165 documents

Tumor hypoxia in pelvic recurrences of cervical cancer.

1998

We have previously demonstrated in primary cancer of the uterine cervix that tumor hypoxia, as determined polarographically, is strongly associated with clinical malignant progression of the disease. Having applied a similar methodological approach to investigate loco-regional relapses, we found a pronounced shift to more hypoxic oxygenation profiles in the recurrent tumors than in the primary tumors. Median pO2 values in 53 pelvic recurrences were significantly lower than the median pO2 values of 117 primary tumors of comparable sizes (7.1 +/- 1.1 mmHg vs. 12.1 +/- 1.0 mmHg, p = 0.0013). The differences in tumor oxygenation between primary and recurrent tumors mirrored the differences in t…

AdultCancer ResearchPathologymedicine.medical_specialtyPartial PressureUrologyUterine Cervical NeoplasmsDiseaseAdenocarcinomaCarcinoma AdenosquamousmedicineHumansAgedPelvic NeoplasmsCervical cancerTumor hypoxiabusiness.industryOxygenationPelvic cavityHypoxia (medical)Tumor OxygenationMiddle Agedmedicine.diseaseOxygenmedicine.anatomical_structureOncologyCohortCarcinoma Squamous CellFemalemedicine.symptomNeoplasm Recurrence LocalbusinessPolarographyInternational journal of cancer
researchProduct

Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3).

2007

Persistent infection with human papillomaviruses (HPV) is a prerequisite for the development of cervical cancer. Vaccination with virus-like particles (VLP) has demonstrated efficacy in prophylaxis but lacks therapeutic potential. HPV16 L1E7 chimeric virus-like particles (CVLP) consist of a carboxy-terminally truncated HPV16L1 protein fused to the amino-terminal part of the HPV16 E7 protein and self-assemble by recombinant expression of the fusion protein. The CVLP are able to induce L1- and E7-specific cytotoxic T lymphocytes. We have performed a first clinical trial to gain information about the safety and to generate preliminary data on the therapeutic potential of the CVLP in humans. A …

AdultCancer ResearchTime FactorsOncogene Proteins FusionvirusesUterine Cervical NeoplasmsCervical intraepithelial neoplasiaCancer VaccinesDrug Administration ScheduleDouble-Blind MethodMedicineHumansPapillomavirus VaccinesAdverse effectAgedCervical cancerHuman papillomavirus 16biologybusiness.industryPapillomavirus Infectionsvirus diseasesOncogene Proteins ViralMiddle Agedmedicine.diseaseUterine Cervical Dysplasiafemale genital diseases and pregnancy complicationsVaccinationClinical trialTumor Virus InfectionsTreatment OutcomeOncologyImmunizationHigh Grade Cervical Intraepithelial NeoplasiaImmunologyDNA Viralbiology.proteinFemaleAntibodybusinessInternational journal of cancer
researchProduct

Validity of Laparoscopic Staging to Avoid Adjuvant Chemoradiation following Radical Surgery in Patients with Early Cervical Cancer

2012

<b><i>Purpose:</i></b> To determine the rate of unavoidable adjuvant chemoradiation (RCTX) due to histologic results after radical surgery in patients with early cervical cancer. <b><i>Patients and Methods:</i></b> Between May 2004 and July 2011, 448 consecutive patients diagnosed with invasive cervical cancer stage IA1 L1 to IIA underwent laparoscopic staging at the Department of Gynecology and Gynecologic Oncology at Charité Berlin. Only in patients without lymph node metastases (n = 394) on frozen section, radical operation was continued either by laparoscopic radical hysterectomy (n = 228) or by radical vaginal trachelectomy (n = 166). The…

AdultCancer Researchmedicine.medical_specialtyAdolescentmedicine.medical_treatmentUterine Cervical NeoplasmsRadical vaginal trachelectomyAdjuvant chemoradiationHysterectomyYoung AdultRisk FactorsEarly cervical cancermedicineHumansRadical hysterectomyProspective StudiesRadical HysterectomyRadical surgeryLaparoscopyProspective cohort studyAgedNeoplasm StagingAged 80 and overCervical cancerHysterectomymedicine.diagnostic_testbusiness.industryGeneral surgeryChemoradiotherapy AdjuvantGeneral MedicineMiddle Agedmedicine.diseaseSettore MED/40 - Ginecologia E OstetriciaSurgeryClinical trialOncologyLymphatic MetastasisAdjuvant chemoradiation; Early cervical cancer; Radical hysterectomyVaginaLymph Node ExcisionFemaleLaparoscopyRisk factorbusinessChemoradiotherapy
researchProduct

A randomized trial comparing conventional cytology to liquid-based cytology and computer assistance.

2012

Liquid-based cytology (LBC) has replaced conventional cytology (CC) for cervical cancer screening in some countries. However, it remains unclear whether LBC is superior to CC. A randomized controlled trial was conducted between August 2007 and March 2009 in Germany to compare LBC, alone and in combination with computer-assisted imaging technology (CAS), to CC in the detection of histologically confirmed cervical intraepithelial neoplasia (CIN). The main outcome measures were detection rates, relative sensitivities, positive predictive values (PPVs) and relative PPVs comparing LBC without and with CAS to CC. Primary histological outcome was CIN2 or higher. Included were 20,627 women particip…

AdultCancer Researchmedicine.medical_specialtyCytodiagnosisUterine Cervical NeoplasmsCervical intraepithelial neoplasiaGastroenterologySensitivity and Specificitylaw.inventionYoung AdultRandomized controlled triallawConventional cytologyCytologyInternal medicineMedicineHumansEarly Detection of CancerAgedGynecologyColposcopymedicine.diagnostic_testbusiness.industryReproducibility of ResultsMiddle Agedmedicine.diseaseConfidence intervalClinical trialOncologyLiquid-based cytologyFemalebusinessInternational journal of cancer
researchProduct

Prospective study on cervical neoplasia IV. Presence of HPV antibodies.

1999

Sera collected in the course of a prospective study carried out in Prague in 1975–1983 were assayed for the presence of human papillomavirus (HPV) antibodies. Women with cervical neoplasia proven by biopsy at enrollment possessed antibodies to peptides derived from E2, E4 and E7 proteins of HPV16 and to virus-like particles (VLPs) of HPV16, -18 and -33 significantly more frequently than matched controls. Women without cervical neoplasia at enrollment who developed the disease in the course of the study differed from matched controls by a higher prevalence of antibodies against VLPs of HPV16 and -18 but not against early antigens of HPV16. In 19 of the latter subjects, paired serum specimens…

AdultCancer Researchmedicine.medical_specialtyvirusesPapillomavirus E7 ProteinsUterine Cervical NeoplasmsAntibodies ViralGastroenterologySerologyAntigenInternal medicineBiopsymedicineHumansProspective StudiesSeroconversionProspective cohort studyPapillomaviridaebiologymedicine.diagnostic_testbusiness.industryvirus diseasesCancerOncogene Proteins ViralMiddle Agedmedicine.diseasefemale genital diseases and pregnancy complicationsDNA-Binding ProteinsOncologyImmunologybiology.proteinFemaleViral diseaseAntibodybusinessBiomarkersInternational journal of cancer
researchProduct

Magnetically labeled water perfusion imaging of the uterine arteries and of normal and malignant cervical tissue: initial experiences.

1998

Purpose: The aim of this pilot study was to evaluate a magnetically labeled water perfusion imaging technique as a non-contrast-enhanced approach to demonstrate the uterine artery, its branches, and to assess the cervical uterine blood flow in healthy volunteers and in patients with advanced uterine cervical carcinoma (FIGO IIB-IVA). Methods and Materials: Seven healthy volunteers (mean age, 29 years) and twenty-two patients (mean age, 52 years) with advanced cancer of the uterine cervix (FIGO IIB-IVA) were prospectively examined by magnetically labeled water perfusion imaging at different inversion delay times (300–900 ms). The magnetic resonance imaging (MRI) findings of all patients were…

AdultGadolinium DTPAPathologymedicine.medical_specialtyBiomedical EngineeringBiophysicsHemodynamicsContrast MediaUterine Cervical NeoplasmsPerfusion scanningCervix UteriSensitivity and Specificitymedicine.arterymedicineHumansRadiology Nuclear Medicine and imagingUterine arteryCervixAgedNeoplasm Stagingmedicine.diagnostic_testNeovascularization Pathologicbusiness.industryUterusHemodynamicsWaterMagnetic resonance imagingBlood flowArteriesMiddle AgedImage EnhancementMagnetic Resonance ImagingPerfusionmedicine.anatomical_structureDynamic contrast-enhanced MRIFemaleNuclear medicinebusinessPerfusionBlood Flow VelocityMagnetic resonance imaging
researchProduct

Peritoneal HPV‐DNA test in cervical cancer (PIONEER study): A proof of concept

2020

The aim of this study was to investigate the prevalence of peritoneal human papillomavirus (HPV) infection in different clinical cervical cancer (CC) settings, and its association with potential clinical and/or histological factors. This is a single-center, prospective, observational study. Consecutive patients with newly diagnosed or recurrent/persistent CC, between March 2019 and April 2020, were included. A group of patients undergoing surgery for benign gynecological conditions was included as control group. All patients underwent HPV-DNA test in the cervix and in the peritoneal cavity simultaneously at time of surgery. Two-hundred seventy-two patients had cervical and peritoneal HPV te…

AdultHPVCancer Researchmedicine.medical_specialtyMultivariate analysiscervical cancergenotypemedicine.medical_treatmentUterine Cervical Neoplasmsprognostic factors.GastroenterologyHuman Papillomavirus DNA Tests03 medical and health sciencesPeritoneal cavity0302 clinical medicinegenotypesInternal medicineGenotypemedicineHumansProspective StudiesStage (cooking)Peritoneal CavityCervixAgedNeoplasm StagingAged 80 and overCervical cancerHuman papillomavirus 16Human papillomavirus 18business.industryHPV infectionprognostic factorsMiddle Agedperitoneummedicine.diseaseCervical conizationinfectionSettore MED/40 - GINECOLOGIA E OSTETRICIAmedicine.anatomical_structureOncology030220 oncology & carcinogenesisFemalebusinessInternational Journal of Cancer
researchProduct

Awareness of HPV infection and attitudes toward HPV vaccination among Latvian adolescents

2016

Objective\ud To evaluate awareness of HPV and its vaccine among Latvian adolescents.\ud \ud Methods\ud A cross‐sectional survey was conducted in a 2‐week period in September 2015 among 270 adolescents attending a secondary school in Riga, Latvia. All students present during sexual‐health classes (grades 10–12 [aged 16–21 years]) were included. A self‐administered paper‐based survey assessed sociodemographic factors, sexual behaviours, smear history and knowledge of sexually transmitted infections, HPV and HPV vaccine knowledge, and sources of information.\ud \ud Results\ud Overall, 121 surveys were completed (62 by male students and 59 by female students). Latvian adolescents lacked awarene…

AdultHealth Knowledge Attitudes PracticeAdolescentPopulationUterine Cervical Neoplasms03 medical and health sciencesSexually active0302 clinical medicineRA0421Surveys and QuestionnairesPrevalenceHumansMedicinePapillomavirus Vaccines030212 general & internal medicineeducationFemale studentseducation.field_of_studyHigh prevalencebusiness.industryPapillomavirus InfectionsHPV infectionObstetrics and GynecologyLatvianHpv vaccinationGeneral MedicinePatient Acceptance of Health Caremedicine.diseaseLatviaR1female genital diseases and pregnancy complicationslanguage.human_languageVaccinationAdolescent Behavior030220 oncology & carcinogenesisImmunologylanguageWomen's HealthFemalebusinessDemographyInternational Journal of Gynecology & Obstetrics
researchProduct

Barriers and motivators for uptake of cervical cancer prevention strategies in Eastern Europe: Perspective from Latvia

2019

Introduction The incidence of cervical cancer (CC) in eastern European countries is high; however, uptake of available prevention strategies is suboptimal. We explored knowledge, behaviors, and attitudes toward CC prevention strategies in Latvian women. Methods A mixed-methods study of Latvian women, consisting of surveys and semi-structured interviews, was conducted in Riga, Latvia in September and October 2015. Results Altogether, 158 surveys were completed and 10 interviews were conducted. In total, 87% (n = 135) had previously had a smear test, and 67% (n = 105) correctly identified that cervical cytology was performed to identify precancerous changes. The practice of annual gynecologic…

AdultHealth Knowledge Attitudes Practicemedicine.medical_specialtymedia_common.quotation_subjectUterine Cervical NeoplasmsShameBFDermatologyCohort StudiesRC0254Young AdultRA0421HumansMedicineEurope EasternYoung adultAgedmedia_commonCervical cancerMotivationCervical screeningbusiness.industryIncidence (epidemiology)LatvianMiddle AgedPatient Acceptance of Health Caremedicine.diseaseLatvialanguage.human_languageEastern europeanInfectious DiseasesFamily medicinelanguageFemalebusinessCohort study
researchProduct

How to select early-stage cervical cancer patients still suitable for laparoscopic radical hysterectomy: a propensity-matched study

2020

Background: Recently, it was reported that minimally invasive surgery (MIS) has a negative impact on early-stage cervical cancer (ECC) patient survival. At the same time, advantages of MIS regarding quality of life and low rate of intra- and postoperative complications are well known. Therefore, it is essential to select patients who may benefit from MIS without worsening their oncologic outcomes. The aim of this study is to investigate which pathological factors could guide surgeons’ choice about the best approach in ECC. Patients and Methods: Patients with 2009 FIGO stage from IA1 with lymphovascular space invasion (LVSI) to IB1/IIA1 treated by open or laparoscopic surgery were judged eli…

AdultLaparoscopic surgerymedicine.medical_specialtymedicine.medical_treatmentlaparoscopyUterine Cervical NeoplasmsHysterectomyDisease-Free Survivalopen surgeryYoung Adult03 medical and health sciences0302 clinical medicineSurgical oncologymedicineHumansMinimally Invasive Surgical ProceduresRadical HysterectomyPropensity ScoreLaparoscopyGrading (tumors)minimally invasive surgeryAgedNeoplasm StagingRetrospective StudiesAged 80 and overCervical cancermedicine.diagnostic_testbusiness.industryParametrialCervical cancer; laparoscopy; minimally invasive surgery; open surgery; radical hysterectomy; tumor diameterHazard ratioMiddle Agedmedicine.diseaseSurgerySurvival RateTreatment OutcomeSettore MED/40 - GINECOLOGIA E OSTETRICIAItalyOncology030220 oncology & carcinogenesisradical hysterectomyCervical cancerFemale030211 gastroenterology & hepatologySurgerytumor diameterbusiness
researchProduct